SCHEMBL3328246

SCHEMBL3328246

O=Cc1cc(Cl)c(Cl)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17130147 0.76
SCHEMBL16313404 0.76
SCHEMBL950696 0.76
SCHEMBL6626975 0.76
SCHEMBL27347986 0.76
SCHEMBL153355 0.72 CYP2A6 (0.34)
SCHEMBL31178518 0.72 CYP2A6 (0.34)
SCHEMBL15562550 0.72 VCAM1 (0.42)
SCHEMBL17398207 0.72 CYP2A6 (0.33)
SCHEMBL31178529 0.72 CYP2A6 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104098558-A Amide compound and preparation method thereof CHANGZHOU NO 4 PHARMACEUTICAL FACTORY CO LTD 2014-10-15 CN claimed
CN-112272670-B Di-ring derivative-containing inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-12-12 CN disclosed
CN-112272670-A Bicyclic derivative-containing inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-01-26 CN disclosed
CN-109369611-B Synthetic method of 4-chlorothiophene-2-carbonyl derivative 上海毕得医药科技有限公司 2020-11-10 CN disclosed
EP-3153511-B1 2-ACYLAMINOTHIAZOLE DERIVATIVE FOR USE IN THE PREVENTION OR TREATMENT OF BLADDER/URINARY TRACT DISEASES ASTELLAS PHARMA INC (JP) 2019-05-15 EP disclosed
EP-2947085-B1 OXAZOLIDONE COMPOUNDS, METHOD FOR PREPARING AND APPLICATION THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2017-09-13 EP disclosed
CN-104098558-B Amides compound and preparation method thereof 常州市第四制药厂有限公司 2016-07-06 CN disclosed
EP-2947085-A1 OXAZOLIDONE COMPOUND, PREPARING METHOD AND APPLICATION THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2015-11-25 EP disclosed
CN-104098558-A Amide compound and preparation method thereof CHANGZHOU NO 4 PHARMACEUTICAL FACTORY CO LTD 2014-10-15 CN disclosed
WO-2014110971-A1 OXAZOLIDONE COMPOUND, PREPARING METHOD AND APPLICATION THEREOF 中国科学院上海药物研究所 (CN) 2014-07-24 WO disclosed
EP-1521582-A1 2,5-SUBSTITUTED PYRIMIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-04-13 EP disclosed
WO-2005020987-A1 HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSES GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-03-10 WO disclosed
WO-2005020986-A1 HETEROCYCLIC AMIDE DERIVATIVES WHICH POSSES GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2005-03-10 WO disclosed
US-20040014775-A1 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists ROCHE PALO ALTO LLC 2004-01-22 US disclosed
WO-2004004731-A1 2, 5-SUBSTITUTED PYRIMIDINE DERIVATIVES AS CCR-3 RECEPTOR ANTAGONISTS IX F. HOFFMANN-LA ROCHE AG (CH) 2004-01-15 WO disclosed
EP-0874848-A1 PYRIMIDINE DERIVATIVES AND GUANINE DERIVATIVES, AND THEIR USE IN TREATING TUMOUR CELLS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-11-04 EP disclosed
WO-1997020843-A1 PYRIMIDINE DERIVATIVES AND GUANINE DERIVATIVES, AND THEIR USE IN TREATING TUMOUR CELLS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1997-06-12 WO disclosed
US-5405865-A Pyrethroid esters ROUSSEL-UCLAF (FR) 1995-04-11 US disclosed
EP-0555153-A1 Pyrethrinoide esters, derivatives of furan- or thiophenalcohol, process for their preparation and application thereof as pesticides ROUSSEL UCLAF (FR) 1993-08-11 EP disclosed
US-4192884-A Substituted 4-(((thienyl)methyl)-amino)benzoic acids and a method for treating hypolipidemia THE DOW CHEMICAL COMPANY (US) 1980-03-11 US disclosed